These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
555 related articles for article (PubMed ID: 31509261)
1. A hMTR4-PDIA3P1-miR-125/124-TRAF6 Regulatory Axis and Its Function in NF kappa B Signaling and Chemoresistance. Xie C; Zhang LZ; Chen ZL; Zhong WJ; Fang JH; Zhu Y; Xiao MH; Guo ZW; Zhao N; He X; Zhuang SM Hepatology; 2020 May; 71(5):1660-1677. PubMed ID: 31509261 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3. Zhao N; Wang R; Zhou L; Zhu Y; Gong J; Zhuang SM Mol Cancer; 2014 Feb; 13():35. PubMed ID: 24565101 [TBL] [Abstract][Full Text] [Related]
3. SNHG16/miR-605-3p/TRAF6/NF-κB feedback loop regulates hepatocellular carcinoma metastasis. Hu YL; Feng Y; Chen YY; Liu JZ; Su Y; Li P; Huang H; Mao QS; Xue WJ J Cell Mol Med; 2020 Jul; 24(13):7637-7651. PubMed ID: 32436333 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2. Tu C; Chen W; Wang S; Tan W; Guo J; Shao C; Wang W J Cell Mol Med; 2019 Nov; 23(11):7190-7199. PubMed ID: 30801960 [TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine exerts cardioprotective effect through miR-146a-3p targeting IRAK1 and TRAF6 via inhibition of the NF-κB pathway. He L; Wang Z; Zhou R; Xiong W; Yang Y; Song N; Qian J Biomed Pharmacother; 2021 Jan; 133():110993. PubMed ID: 33220608 [TBL] [Abstract][Full Text] [Related]
6. Circ_0114427 promotes LPS-induced septic acute kidney injury by modulating miR-495-3p/TRAF6 through the NF-κB pathway. Xu L; Cao H; Xu P; Nie M; Zhao C Autoimmunity; 2022 Feb; 55(1):52-64. PubMed ID: 34730059 [TBL] [Abstract][Full Text] [Related]
7. Hypoxia-induced lncRNA PDIA3P1 promotes mesenchymal transition via sponging of miR-124-3p in glioma. Wang S; Qi Y; Gao X; Qiu W; Liu Q; Guo X; Qian M; Chen Z; Zhang Z; Wang H; Xu J; Xue H; Guo X; Zhang P; Zhao R; Li G Cell Death Dis; 2020 Mar; 11(3):168. PubMed ID: 32127518 [TBL] [Abstract][Full Text] [Related]
8. LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22. Zhu K; Yuan Y; Wen J; Chen D; Zhu W; Ouyang Z; Wang W Aging (Albany NY); 2020 Apr; 12(8):6644-6666. PubMed ID: 32302291 [TBL] [Abstract][Full Text] [Related]
9. MiR-146a protects small intestine against ischemia/reperfusion injury by down-regulating TLR4/TRAF6/NF-κB pathway. He X; Zheng Y; Liu S; Shi S; Liu Y; He Y; Zhang C; Zhou X J Cell Physiol; 2018 Mar; 233(3):2476-2488. PubMed ID: 28771774 [TBL] [Abstract][Full Text] [Related]
10. Knockdown of Long Non-Coding RNA XIST Inhibited Doxorubicin Resistance in Colorectal Cancer by Upregulation of miR-124 and Downregulation of SGK1. Zhu J; Zhang R; Yang D; Li J; Yan X; Jin K; Li W; Liu X; Zhao J; Shang W; Yu T Cell Physiol Biochem; 2018; 51(1):113-128. PubMed ID: 30439718 [TBL] [Abstract][Full Text] [Related]
11. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p. Wang B; Xu L; Zhang J; Cheng X; Xu Q; Wang J; Mao F Biomed Pharmacother; 2020 Sep; 129():110268. PubMed ID: 32563146 [TBL] [Abstract][Full Text] [Related]
12. miR-146b antagomir-treated human Tregs acquire increased GVHD inhibitory potency. Lu Y; Hippen KL; Lemire AL; Gu J; Wang W; Ni X; Ranganathan P; Levine BL; Riley JL; June CH; Turka LA; Munn DH; Garzon R; Lu L; Blazar BR Blood; 2016 Sep; 128(10):1424-35. PubMed ID: 27485827 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-760 Inhibits Doxorubicin Resistance in Hepatocellular Carcinoma through Regulating Notch1/Hes1-PTEN/Akt Signaling Pathway. Tian T; Fu X; Lu J; Ruan Z; Nan K; Yao Y; Yang Y J Biochem Mol Toxicol; 2018 Aug; 32(8):e22167. PubMed ID: 29968951 [TBL] [Abstract][Full Text] [Related]
14. Resveratrol protects BV2 mouse microglial cells against LPS-induced inflammatory injury by altering the miR-146a-5p/TRAF6/NF-κB axis. Ge YT; Zhong AQ; Xu GF; Lu Y Immunopharmacol Immunotoxicol; 2019 Oct; 41(5):549-557. PubMed ID: 31530042 [No Abstract] [Full Text] [Related]
15. Long non-coding RNA CTA sensitizes osteosarcoma cells to doxorubicin through inhibition of autophagy. Wang Z; Liu Z; Wu S Oncotarget; 2017 May; 8(19):31465-31477. PubMed ID: 28415557 [TBL] [Abstract][Full Text] [Related]
16. PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition. Gao Z; Xu J; Fan Y; Qi Y; Wang S; Zhao S; Guo X; Xue H; Deng L; Zhao R; Sun C; Zhang P; Li G J Exp Clin Cancer Res; 2022 Jul; 41(1):223. PubMed ID: 35836243 [TBL] [Abstract][Full Text] [Related]
17. IL-8 regulates the doxorubicin resistance of colorectal cancer cells via modulation of multidrug resistance 1 (MDR1). Du J; He Y; Li P; Wu W; Chen Y; Ruan H Cancer Chemother Pharmacol; 2018 Jun; 81(6):1111-1119. PubMed ID: 29693201 [TBL] [Abstract][Full Text] [Related]
18. miR-509-5p anti-infection response for mycoplasma pneumonia in sheep by targeting NF-κB pathway. Zhu M; Cao S; Zheng W; Zhai M; Wang M; Blair HT; Morris ST; Zhang H; Zhao Z Vet Immunol Immunopathol; 2021 Aug; 238():110275. PubMed ID: 34153741 [TBL] [Abstract][Full Text] [Related]
19. Pseudogene PDIA3P1 promotes cell proliferation, migration and invasion, and suppresses apoptosis in hepatocellular carcinoma by regulating the p53 pathway. Kong Y; Zhang L; Huang Y; He T; Zhang L; Zhao X; Zhou X; Zhou D; Yan Y; Zhou J; Xie H; Zhou L; Zheng S; Wang W Cancer Lett; 2017 Oct; 407():76-83. PubMed ID: 28823960 [TBL] [Abstract][Full Text] [Related]
20. ING4 suppresses hepatocellular carcinoma via a NF-κB/miR-155/FOXO3a signaling axis. Qian F; Hu Q; Tian Y; Wu J; Li D; Tao M; Qin L; Shen B; Xie Y Int J Biol Sci; 2019; 15(2):369-385. PubMed ID: 30745827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]